adamantane has been researched along with Prediabetes in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 6 (75.00) | 24.3611 |
| 2020's | 2 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bermudez Saint Andre, K; Coverdale, S; Dursteler, A; Gutierrez, AD; Hamidi, V; Miller Iii, C; Riggs, K; Taegtmeyer, H; Wang, H; Westby, C; Zhu, L | 1 |
| Apaijai, N; Chattipakorn, N; Chattipakorn, SC; Chunchai, T; Jaiwongkam, T; Kerdphoo, S; Pratchayasakul, W; Saiyasit, N; Sripetchwandee, J | 1 |
| Apaijai, N; Chattipakorn, N; Chattipakorn, SC; Jiang, C; Li, X; Liang, G; Sa-Nguanmoo, P; Tanajak, P; Wang, X | 1 |
| Chen, Q; Huang, L; Kong, L; Wang, J; Wang, Z; Xu, D; Zhang, T; Zhou, X | 1 |
| Chiamvimonvat, N; Despa, F; Despa, S; Dong, H; Hammock, BD; Harris, TR; Li, N; Margulies, KB; Sharma, S; Taegtmeyer, H | 1 |
| Apaijai, N; Chattipakorn, N; Chattipakorn, SC; Khamseekaew, J; Pintana, H; Siri-Angkul, N; Tanajak, P | 1 |
| Elkind-Hirsch, KE; Gutowski, HC; Paterson, MS; Seidemann, EL | 1 |
| Dejager, S; Foley, JE; Schweizer, A | 1 |
1 review(s) available for adamantane and Prediabetes
| Article | Year |
|---|---|
Evidence to support the use of vildagliptin monotherapy in the treatment of type 2 diabetes mellitus.
Topics: Adamantane; Age Factors; Aged; Animals; Biomarkers; Blood Glucose; Diabetes Mellitus, Type 2; Dipeptidyl-Peptidase IV Inhibitors; Evidence-Based Medicine; Glycated Hemoglobin; Humans; Middle Aged; Nitriles; Patient Selection; Prediabetic State; Pyrrolidines; Risk Assessment; Severity of Illness Index; Treatment Outcome; Vildagliptin | 2012 |
3 trial(s) available for adamantane and Prediabetes
| Article | Year |
|---|---|
Acute Exenatide Therapy Attenuates Postprandial Vasodilation in Humans with Prediabetes: A Randomized Controlled Trial.
Topics: Adamantane; Adult; Aged; Biomarkers; Blood Glucose; Cross-Over Studies; Dietary Fats; Dipeptides; Double-Blind Method; Exenatide; Female; Forearm; Humans; Incretins; Insulin; Lipids; Male; Middle Aged; Obesity; Postprandial Period; Prediabetic State; Texas; Time Factors; Treatment Outcome; Vasodilation | 2020 |
Effects of saxagliptin on glucose homeostasis and body composition of obese patients with newly diagnosed pre-diabetes.
Topics: Adamantane; Adult; Blood Glucose; Diabetes Mellitus, Type 2; Diet; Dipeptides; Dipeptidyl-Peptidase IV Inhibitors; Female; Glucose Intolerance; Homeostasis; Humans; Insulin Resistance; Life Style; Male; Metformin; Middle Aged; Obesity; Postprandial Period; Prediabetic State; Treatment Outcome | 2017 |
Short-term therapy with combination dipeptidyl peptidase-4 inhibitor saxagliptin/metformin extended release (XR) is superior to saxagliptin or metformin XR monotherapy in prediabetic women with polycystic ovary syndrome: a single-blind, randomized, pilot
Topics: Adamantane; Adiposity; Adolescent; Adult; Androgens; Biomarkers; Blood Glucose; Delayed-Action Preparations; Dipeptides; Dipeptidyl-Peptidase IV Inhibitors; Drug Administration Schedule; Drug Combinations; Female; Glucose Tolerance Test; Humans; Hypoglycemic Agents; Insulin; Menstrual Cycle; Metformin; Pilot Projects; Polycystic Ovary Syndrome; Prediabetic State; Single-Blind Method; Time Factors; Treatment Outcome; Young Adult | 2017 |
4 other study(ies) available for adamantane and Prediabetes
| Article | Year |
|---|---|
Neurotensin receptor 1 agonist provides neuroprotection in pre-diabetic rats.
Topics: Adamantane; Animals; Cognitive Dysfunction; Diet, High-Fat; Drug Evaluation, Preclinical; Drug Therapy, Combination; Hippocampus; Ileum; Imidazoles; Insulin Resistance; Male; Neuronal Plasticity; Obesity; Oligopeptides; Oxidative Stress; Prediabetic State; Random Allocation; Rats, Wistar; Receptors, Neurotensin | 2021 |
Comparisons of cardioprotective efficacy between fibroblast growth factor 21 and dipeptidyl peptidase-4 inhibitor in prediabetic rats.
Topics: Adamantane; Animals; Cardiotonic Agents; Diabetic Cardiomyopathies; Diet, High-Fat; Dipeptidyl-Peptidase IV Inhibitors; Fibroblast Growth Factors; Gene Expression Regulation; Heart Rate; Humans; Hypoglycemic Agents; Insulin Resistance; Male; Mitochondria, Heart; Nitriles; Obesity; Prediabetic State; Pyrrolidines; Rats; Rats, Wistar; Recombinant Proteins; Tumor Necrosis Factor-alpha; Ventricular Dysfunction, Left; Vildagliptin | 2017 |
Cardioprotection by controlling hyperamylinemia in a "humanized" diabetic rat model.
Topics: Adamantane; Animals; Animals, Genetically Modified; Calcium; Cardiomegaly; Diabetes Mellitus, Type 2; Disease Models, Animal; Eicosanoids; Epoxide Hydrolases; Heart; Humans; Insulin-Secreting Cells; Islet Amyloid Polypeptide; Myocardium; Myocytes, Cardiac; Obesity; Oxidative Stress; Pancreas; Prediabetic State; Rats; Sarcolemma; Urea | 2014 |
Vildagliptin and caloric restriction for cardioprotection in pre-diabetic rats.
Topics: Adamantane; Animals; Blood Glucose; Body Weight; Caloric Restriction; Cardiotonic Agents; Diet, High-Fat; Fibroblast Growth Factors; Heart Rate; Insulin Resistance; Intra-Abdominal Fat; Male; Mitochondria, Heart; Nitriles; Oxidative Stress; Prediabetic State; Pyrrolidines; Rats; Rats, Wistar; Ventricular Function, Left; Vildagliptin | 2017 |